In recent years, renewed research into psychedelic-assisted psychotherapy has sparked growing interest among clinicians, researchers, and patients seeking deeper healing from trauma, depression, anxiety, and existential distress. Substances such as Psilocybin, MDMA, and Ketamine are being studied in clinical settings at institutions like Johns Hopkins Center for Psychedelic and Consciousness Research and MAPS. At the same time, many therapists are discovering that psychedelic

Our modern world is dominated by screens, a frantic sense of busyness, an ever-increasing isolation from others, and a detachment from...